Alertas Bibliográficas


Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen I Stone, Ashok Balasubramanyam, Jennifer E Posey 
Diabetes Care. 2024 May 1;47(5):770-781.

Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
Katherine L Modzelewski, Alexandra Pipilas, Nicholas A Bosch
JAMA Netw Open . 2024 May 1;7(5):e249305.


Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
Eystein S Husebye, Frederik Castinetti, et al. 
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21.

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret C S Boguszewski, Cesar L Boguszewski , et al. 
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52.

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
John P Bilezikian 1, Aliya A Khan, et al. 
J Bone Miner Res. 2022 Nov;37(11):2293-2314.

Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Antonio Marcondes Lerario, Dipika R Mohan, Gary D Hammer, et al.  
Endocr Rev. 2022 Nov 25;43(6):1051-1073.

Management of thyroid eye disease: a Consensus Statement by the American Thyroid  Association and the European Thyroid Association. 
Burch, H. B., Perros, P.,  et al.  
Eur Thyroid J. 2022 Dec 1; 11(6): e220189.

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. 
Coleman, E., Radix, A. E. et al. 
International journal of transgender health, 23(Suppl 1), S1–S259.

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Ghada El-Hajj Fuleihan, Gregory A Clines, et al.
J Clin Endocrinol Metab. 2023 Feb 15;108(3):507-528. doi: 10.1210/clinem/dgac621.
DOI: 10.1210/clinem/dgac621

Diagnosis and Management of Central Diabetes Insipidus in Adults
Maria Tomkins, Sarah Lawless, et al.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. 
doi: 10.1210/clinem/dgac381


Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al.
N Engl J Med. 2019 Aug 15;381(7):637-646.

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D, Aversa T, Ruggeri RM, Cristani M, Alibrandi A, et al.
Front Endocrinol (Lausanne). 2019 Jun 28;10:426.